BERARDELLI, RITA
 Distribuzione geografica
Continente #
NA - Nord America 2.543
EU - Europa 1.292
AS - Asia 948
SA - Sud America 102
AF - Africa 14
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.910
Nazione #
US - Stati Uniti d'America 2.489
CN - Cina 367
SG - Singapore 324
SE - Svezia 236
IT - Italia 177
UA - Ucraina 148
IE - Irlanda 146
DE - Germania 130
FI - Finlandia 110
FR - Francia 94
BR - Brasile 83
KR - Corea 77
PL - Polonia 56
GB - Regno Unito 46
CA - Canada 44
VN - Vietnam 38
NL - Olanda 33
JP - Giappone 30
AT - Austria 24
IN - India 22
BE - Belgio 18
PH - Filippine 17
RU - Federazione Russa 15
GR - Grecia 14
DK - Danimarca 13
HK - Hong Kong 12
ID - Indonesia 11
UZ - Uzbekistan 10
MX - Messico 9
AR - Argentina 8
AU - Australia 8
ES - Italia 7
LB - Libano 7
LT - Lituania 6
IR - Iran 5
RS - Serbia 5
TR - Turchia 5
TW - Taiwan 5
PK - Pakistan 4
SA - Arabia Saudita 4
EG - Egitto 3
MA - Marocco 3
PT - Portogallo 3
RO - Romania 3
ZA - Sudafrica 3
CO - Colombia 2
CY - Cipro 2
EC - Ecuador 2
GY - Guiana 2
HR - Croazia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
TN - Tunisia 2
VE - Venezuela 2
AZ - Azerbaigian 1
BD - Bangladesh 1
BO - Bolivia 1
CH - Svizzera 1
DZ - Algeria 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
MK - Macedonia 1
MT - Malta 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
PE - Perù 1
SD - Sudan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.910
Città #
Chandler 397
Beijing 272
Houston 216
Santa Clara 209
Singapore 182
Dublin 146
Dearborn 113
Ann Arbor 109
Ashburn 78
Fairfield 77
Jacksonville 68
Wilmington 68
Nyköping 66
Torino 54
Princeton 48
Villeurbanne 43
Warsaw 40
Columbus 39
Medford 39
Woodbridge 39
Munich 36
Seattle 35
Redwood City 30
Pisa 29
Cambridge 27
New York 25
Toronto 25
Boston 24
Vienna 24
Fremont 22
San Mateo 19
Düsseldorf 16
Brussels 15
Dong Ket 15
Guangzhou 15
Boardman 14
Helsinki 14
Hong Kong 12
Norwalk 11
Jakarta 10
Nanjing 10
Turku 10
Los Angeles 9
Milan 9
Portland 9
Chicago 8
Kunming 8
Hefei 7
Lauterbourg 7
Nuremberg 7
Silver Spring 7
Tokyo 7
Washington 7
London 6
Paris 6
Phoenix 6
Poznan 6
Rome 6
Shanghai 6
Belgrade 5
Belo Horizonte 5
Brisbane 5
Osaka 5
Pune 5
Athens 4
Barcelona 4
Buffalo 4
Durham 4
Falkenstein 4
Falls Church 4
Jinan 4
Kharkiv 4
Leiden 4
Munro 4
Newcastle upon Tyne 4
San Diego 4
San Francisco 4
Shenyang 4
Taipei 4
Verona 4
Amsterdam 3
Ankara 3
Ashland 3
Brooklyn 3
Castellammare di Stabia 3
Chengdu 3
Chennai 3
Concord 3
Frankfurt am Main 3
Frisco 3
Gwangju 3
Honkomagome 3
Lachine 3
New Rochelle 3
Ottawa 3
Pittsburgh 3
Polska 3
Portsmouth 3
Rijnsburg 3
Rio de Janeiro 3
Totale 3.011
Nome #
CUSHING'S SYNDROME IS ASSOCIATED WITH SLEEP ALTERATIONS DETECTED BY WRIST ACTIGRAPHY 378
BCLI POLYMORPHISM OF THE GLUCOCORTICOID RECEPTOR GENE IS ASSOCIATED WITH INCREASED OBESITY, IMPAIRED GLUCOSE TOLERANCE AND DYSLIPIDEMIA IN PATIENTS WITH ADDISON’S DISEASE 320
ACUTE ADMINISTRATION OF ALPRAZOLAM, A BENZODIAZEPINE ACTIVATING GABA RECEPTORS, INHIBITS CORTISOL SECRETION IN PATIENTS WITH SUBCLINICAL BUT NOT OVERT CUSHING'S SYNDROME 273
Enhanced oxidative stress and platelet activation in patients with Cushing's syndrome. 268
IMPROVEMENT OF ANTHROPOMETRIC AND METABOLIC PARAMETERS, AND QUALITY OF LIFE FOLLOWING TREATMENT WITH DUAL-RELEASE HYDROCORTISONE IN PATIENTS WITH ADDISON'S DISEASE 194
Neuroendocrine effects of citalopram, a selective serotonine re-uptake inhibitor, during life span in humans 159
ROLE OF MINERALOCORTICOID RECEPTORS ON HPA AXIS IN HUMANS 140
Secondary adrenal insufficiency: Where is it hidden and what does it look like? 128
THE ACUTE EFFECT OF FLUDROCORTISONE ON BASAL AND HCRH-STIMULATED HYPOTHALAMIC-PITUITARY-ADRENAL (HPA) AXIS IN HUMANS 125
DUAL-RELEASE HYDROCORTISONE IN ADDISON’S DISEASE-A REVIEW OF THE LITERATURE 117
EFFECTS OF CETRORELIX, A GnRH-RECEPTOR ANTAGONIST, ON GONADAL AXIS IN WOMEN WITH FUNCTIONAL HYPOTHALAMIC AMENORRHEA 114
GLUCOCORTICOID RECEPTOR POLYMORPHISMS AND METABOLIC-CARDIOVASCULAR PROFILE IN PATIENTS WITH ADDISON’S DISEASE UNDER REPLACEMENT THERAPY 113
Effect of acute and prolonged mineralocorticoid receptor blockade on spontaneous and stimulated hypothalamus-pituitary-adrenal (HPA) axis in humans 112
EFFECTS OF GNRH-RECEPTOR BLOCKADE ON GONADAL AXIS IN WOMEN WITH FUNCTIONAL HYPOTHALAMIC AMENORRHEA 109
EFFECT OF PROLONGED TREATMENT WITH POTASSIUM CANRENOATE, A MR ANTAGONIST, ON BASAL AND STIMULATED HYPOTHALAMUS-PITUITARY-ADRENAL (HPA) AXIS IN HUMANS 100
THE ACUTE EFFECT OF A MINERALOCORTICOID RECEPTOR AGONIST ON CORTICOTROPE SECRETION IN ADDISON'S DISEASE 97
METABOLIC AND CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT ETIOLOGY BEFORE AND 1 YEAR AFTER DISEASE REMISSION 97
METABOLIC AND CARDIOVASCULAR PROFILE IN PATIENTS WITH ADDISON’S DISEASE UNDER CONVENTIONAL GLUCOCORTICOID REPLACEMENT 96
Ghrelin, hypothalamus-pituitary-adrenal (HPA) axis and Cushing's syndrome 94
Metabolic and cardiovascular profile in patients with Addison's disease under conventional glucocorticoid replacement 94
HORMONAL, METABOLIC AND BONE EVALUATION IN A SERIES OF ADRENAL INCIDENTALOMAS 93
PATIENTS WITH AUTOIMMUNE DISEASES SHOWED ENHANCED BASAL AND STIMULATED CORTICOTROPH SECRETION 92
Retrospective observational analysis of non-irradiated non-functioning pituitary adenomas 90
CONVENTIONAL GLUCOCORTICOID REPLACEMENT THERAPY IN PATIENTS WITH ADDISON’S DISEASE: EFFECT ON METABOLIC AND BONE PARAMETERS 88
Neuroregulation of the hypothalamus-pituitary-adrenal (Hpa) axis in humans: effects of Gaba-, mineralcortoid-, and gh-secretagogue-receptor modulation 88
COMPARISON BETWEEN ITT, METYRAPONE AND ACTH STIMULATION WITH HIGH, LOW AND VERY LOW DOSES FOR DIAGNOSIS OF SECONDARY HYPOADRENALISM 86
WRIST ACTIGRAPHY DOES NOT REVEAL SLEEP DISTURBANCES IN PATIENTS WITH ADDISON’S DISEASE UNDER CONVENTIONAL GLUCOCORTICOID REPLACEMENT THERAPY 86
NEUROENDOCRINE EFFECTS OF CITALOPRAM, A SELECTIVE SEROTONIN RE-UPTAKE INHIBITOR (SSRI), DURING LIFESPAN IN HUMANS 85
THE INHIBITORY EFFECT OF FLUDROCORTISONE ON HPA AXIS IS NOT ONLY EXERTED THROUGH HIPPOCAMPAL MR RECEPTORS: POSSIBLE CLINICAL IMPLICATIONS 84
Long-term morphological, hormonal and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas 82
METABOLIC AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT AETIOLOGY DURING ACTIVE DISEASE AND 1 YEAR AFTER REMISSION 82
Hypothalamus-pituitary-adrenal axis evaluation in patients with hypothalamo-pituitary disorders: comparison of different provocative test 78
NEUROENDOCRINE EFFECT OF CITALOPRAM, A SELECTIVE SEROTONIN RE-UPTAKE INHIBITOR (SSRI), IN ANOREXIA NERVOSA 78
EFFECTS OF CORTISTATIN-17 AND SOMATOSTATIN-14 ON ACTH AND CORTISOL HYPERSECRETION IN PATIENTS WITH CUSHING’S DISEASE 76
Tyrosine kinase inhibitors rechallenge in solid tumors: a review of literature and a case description with lenvatinib in thyroid cancer 76
Insulin and GH-IGF-I axis: endocrine pacer or endocrine disruptor? 75
COMPARISON BETWEEN CORTISOL AND DEXAMETHASONE NEGATIVE FEEDBACK ACTION IN HUMANS 73
Neuroendocrine effects of citalopram, a selective serotonin re-uptake inhibitor (SSRI), in anorexia nervosa. 73
EFFECTS OF GHRELIN ON HYPOTHALAMO-PITUITARY-ADRENAL AXIS IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT ETIOLOGY 70
LONG-TERM MORPHOLOGICAL AND HORMONAL FOLLOW-UP IN A SERIES OF 124 ADRENAL INCIDENTALOMAS 70
SECONDARY ADRENAL INSUFFICIENCY: WHERE IT IS HIDDEN AND HOW IT LOOKS 69
Corticotrope hypersecretion coupled with cortisol hypo-responsiveness to stimuli is present in patients with autoimmune endocrine disease: evidence for subclinical primary hypoadrenalism? 68
Lenvatinib in advanced radioiodine-refractory thyroid cancer: A snapshot of real-life clinical practice 65
Enhanced oxidative stress and platelet activation combined with reduced antioxidant capacity in obese prepubertal and adolescent girls with full or partial metabolic syndrome. 59
WRIST ACTIGRAPHY REVEALS SLEEP DISTURBANCES IN PATIENTS WITH CUSHING’S DISEASE 49
Totale 5.063
Categoria #
all - tutte 15.201
article - articoli 0
book - libri 0
conference - conferenze 5.317
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.518


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202017 0 0 0 0 0 0 0 0 0 0 0 17
2020/2021451 50 45 17 18 64 12 42 39 33 36 36 59
2021/2022612 14 12 15 49 40 24 78 42 26 85 124 103
2022/2023905 89 89 28 114 71 233 46 52 96 32 38 17
2023/2024327 55 55 27 16 17 52 5 14 2 18 19 47
2024/2025977 1 71 38 95 276 65 13 59 126 44 78 111
Totale 5.063